Aublé & Associés accompanies a med-tech company in its €2 million fundraising from two leading innovation capital funds.
Aublé & Associés accompanies a med-tech company in its €2 million fundraising from two leading innovation capital funds.
Aublé & Associés advised a med-tech company in its €2 million fundraising from two leading innovation capital funds.
Founded in January 2019, the startup is developing a platform with augmented intelligence for aggregating and analyzing genomic data in oncology to identify biomarkers and prioritize new cancer drug targets and is working on a drug.
Within the framework of its development, its partners are both academic for the "scientific" part and industrial, for the development, the manufacturing and the marketing of the drug.
Stakeholders on the operation
- Weglot advice and founders: Matthieu Aublé
- Collaborator : Thibaut Lesure
- Advised by Jones Day with Charles Gavoty, partner, and Jérémy Noel, associate.
